GlassScriptPhysician profile
David A Canvasser
NPI 1982711289
$5,263.80
in general payments reported to CMS, 2019-2025
7 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $508 · 2020: $517 · 2021: $432 · 2022: $3,328 · 2023: $146 · 2024: $211 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $479.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $3,480.32 | 2019-2022 | |
| Edwards Lifesciences Corporation | $1,012.88 | 2019-2025 | Mitris Resilia Mitral Valve, Konect Resilia, Sapien 3 Ultra Resilia |
| Abiomed | $558.38 | 2019-2023 | Impella |
| Medtronic Vascular, INC. | $95.43 | 2019 | |
| Abbott Laboratories | $88.96 | 2024 | Amplatzer Talisman |
| Astrazeneca Pharmaceuticals LP | $15.15 | 2019 | |
| Mallinckrodt Enterprises LLC | $12.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Canvasser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.